Skip to content
The People's CodeSearch
Menu

Changes to the Code

H.R. 9102 · BINSA Act ·

In committee · step 2 of 5

Sections are cited like “7 U.S.C. § 2012”: 7 of the , 2012.

50 U.S.C. § 4589 Definitions

+18 −0Shown
More for 50 U.S.C. § 4589
Read § 4589Only this section
3 changes the bill asks for here, 3 carried out
  1. Carried out:

    in paragraph (10)(A), by adding at the end the following:(vi) Biotechnology, meaning the research, development, manufacturing, or commercialization of— (I) pharmaceutical products (which has the meaning given the term “drug” in section 201(g)(1) of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 321(g)(1))); (II) biological …

  2. Carried out:

    in paragraph (7)(A), by adding at the end the following:(vi) Biotechnology, meaning the research, development, manufacturing, or commercialization of— (I) pharmaceutical products (which has the meaning given the term “drug” in section 201(g)(1) of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 321(g)(1))); (II) biological …

  3. Carried out:

    in paragraph (4)(A), by adding at the end the following:(ix) licensing a prohibited technology from a covered foreign person..

§ 4589(4)Covered national security transaction(A)–(B)

Start of § 4589 to (4)(A)(vi) unchanged

WhereMarkThe Code nowMarkAs the bill would leave it
(A)(vii)(vii) (vii)
acquisition of a limited partner or equivalent interest in a venture capital fund, private equity fund, fund of funds, or other pooled investment fund (in each case where the fund is not a United States person) that the United States person has knowledge at the time of the acquisition likely will invest in a person of a country of concern that is in one of the notifiable technology or prohibited technology sectors, and such fund undertakes a transaction that would be a covered national security transaction if undertaken by a United States person; oracquisition of a limited partner or equivalent interest in a venture capital fund, private equity fund, fund of funds, or other pooled investment fund (in each case where the fund is not a United States person) that the United States person has knowledge at the time of the acquisition likely will invest in a person of a country of concern that is in one of the notifiable technology or prohibited technology sectors, and such fund undertakes a transaction that would be a covered national security transaction if undertaken by a United States person; or
(A)(viii)(viii) (viii)
any other transaction identified by the Secretary, in consultation with the appropriate congressional committees and subject to public notice and comment in accordance with subchapter II of chapter 5 and chapter 7 of title 5, and not subject to the requirements of section 4559 of this title, that is contributing to the military, intelligence, surveillance, or cyber-enabled capabilities of a country of concern.any other transaction identified by the Secretary, in consultation with the appropriate congressional committees and subject to public notice and comment in accordance with subchapter II of chapter 5 and chapter 7 of title 5, and not subject to the requirements of section 4559 of this title, that is contributing to the military, intelligence, surveillance, or cyber-enabled capabilities of a country of concern.
(A)(ix)(ix) [inserted: ]
[inserted: licensing a prohibited technology from a covered foreign person.]
(B)(B) Exceptions and clarifications(B) Exceptions and clarifications
Subject to regulations prescribed in accordance with this subchapter, the term “covered national security transaction” does not include—Subject to regulations prescribed in accordance with this subchapter, the term “covered national security transaction” does not include—
(B)(i)(i) (i)
any transaction the value of which the Secretary determines is de minimis;any transaction the value of which the Secretary determines is de minimis;

§ 4589(7)Notifiable technology(A)–(B)

(4)(B)(ii)–(7)(A)(iii) unchanged

WhereMarkThe Code nowMarkAs the bill would leave it
(A)(iv)(iv) (iv)
High-performance computing and supercomputing.High-performance computing and supercomputing.
(A)(v)(v) (v)
Hypersonic systems.Hypersonic systems.
(A)(vi)(vi) [inserted: ]
[inserted: Biotechnology, meaning the research, development, manufacturing, or commercialization of—]
(A)(vi)(I)(I) [inserted: ]
[inserted: pharmaceutical products (which has the meaning given the term “drug” in section 201(g)(1) of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 321(g)(1)));]
(A)(vi)(II)(II) [inserted: ]
[inserted: biological products (as such term is defined in section 351(i) of the Public Health Service Act (42 U.S.C. 262(i))); and]
(A)(vi)(III)(III) [inserted: ]
[inserted: therapeutic compounds, including drug discovery platforms, clinical research and development capabilities, biologics manufacturing, and intellectual property and know-how relating to therapeutic compounds,]
(B)(B) Updates(B) Updates
The Secretary, in consultation with the appropriate congressional committees and subject to notice and comment in accordance with subchapter II of chapter 5 and chapter 7 of title 5, and not subject to the requirements of section 4559 of this title, may prescribe regulations in accordance with this subchapter to—The Secretary, in consultation with the appropriate congressional committees and subject to notice and comment in accordance with subchapter II of chapter 5 and chapter 7 of title 5, and not subject to the requirements of section 4559 of this title, may prescribe regulations in accordance with this subchapter to—
(B)(i)(i) (i)
define the technical parameters of technologies described in subparagraph (A), as reasonably needed for national security purposes; ordefine the technical parameters of technologies described in subparagraph (A), as reasonably needed for national security purposes; or

§ 4589(10)Prohibited technology(A)–(B)

(7)(B)(ii)–(10)(A)(iii) unchanged

WhereMarkThe Code nowMarkAs the bill would leave it
(A)(iv)(iv) (iv)
High-performance computing and supercomputing.High-performance computing and supercomputing.
(A)(v)(v) (v)
Hypersonic systems.Hypersonic systems.
(A)(vi)(vi) [inserted: ]
[inserted: Biotechnology, meaning the research, development, manufacturing, or commercialization of—]
(A)(vi)(I)(I) [inserted: ]
[inserted: pharmaceutical products (which has the meaning given the term “drug” in section 201(g)(1) of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 321(g)(1)));]
(A)(vi)(II)(II) [inserted: ]
[inserted: biological products (as such term is defined in section 351(i) of the Public Health Service Act (42 U.S.C. 262(i))); and]
(A)(vi)(III)(III) [inserted: ]
[inserted: therapeutic compounds, including drug discovery platforms, clinical research and development capabilities, biologics manufacturing, and intellectual property and know-how relating to therapeutic compounds,]
(B)(B) Updates(B) Updates
The Secretary, in consultation with the appropriate congressional committees and subject to notice and comment in accordance with subchapter II of chapter 5 and chapter 7 of title 5, and not subject to the requirements of section 4559 of this title, may prescribe regulations in accordance with this subchapter to—The Secretary, in consultation with the appropriate congressional committees and subject to notice and comment in accordance with subchapter II of chapter 5 and chapter 7 of title 5, and not subject to the requirements of section 4559 of this title, may prescribe regulations in accordance with this subchapter to—
(B)(i)(i) (i)
define the technical parameters of technologies described in subparagraph (A), as reasonably needed for national security purposes; ordefine the technical parameters of technologies described in subparagraph (A), as reasonably needed for national security purposes; or

Rest of § 4589 unchanged

Step through the changes